Lumos Pharma, Inc.
LUMODelisted Dec 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001126234
Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Lumos Pharma, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 40 | 37 | −3 |
| Shares | 3.20M | 2.87M | −336.6K (−10.5%) |
| Value | $32.1M | $27.3M | −$4.81M (−15.0%) |
New holders (4)
Institutions that held Lumos Pharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Minerva Advisors LLC | 34,015 | $321.0K | 0.19% |
| Millennium Management LLC | 15,348 | $146.0K | 0.00% |
| Citadel Advisors LLC | 11,869 | $113.0K | 0.00% |
| Sphinx Trading, LP | 277 | $3.00K | 0.00% |
Sold out (7)
Institutions that held Lumos Pharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Opaleye Management Inc. | 382,000 | $3.82M |
| Paragon Associates & Paragon Associates II Joint Venture | 50,000 | $500.0K |
| Deerfield Management Company, L.P. (Series C) | 33,117 | $331.0K |
| Acadian Asset Management LLC | 2,186 | $22.0K |
| Fifth Third Bancorp | 111 | $1.00K |
| US Bancorp | 111 | $1.00K |
| Bank of America Corp | 19 | $0 |